Episode Details

Back to Episodes
Insulin Cells WITHOUT Immunosuppressants... Dr. Steve Harr, CEO, Sana Biotechnology

Insulin Cells WITHOUT Immunosuppressants... Dr. Steve Harr, CEO, Sana Biotechnology

Episode 25032 Published 1 year, 2 months ago
Description

This week on BioTech Nation, Dr. Steve Harr, CEO of Sana Biotechnology, talks about their progress in Type I diabetics, in particular. The New England Journal of Medicine publishes early success with Sana Biotechnology's engineered insulin-producing cells without immunosuppressant drugs.


Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us